Skip to main content
. 2024 Feb 24;15(8):2110–2122. doi: 10.7150/jca.93373

Table 3.

Univariate and multivariate analysis of FASTKD2 in predicting lung cancer specific survival time.

Category Total number of people (n) Single factor analysis Multivariate analysis
Hazard ratio (95% CI) P value Hazard ratio (95% CI) P value
FASTKD2 503
High expression 251 Reference
Low expression 252 0.500 (0.350-0.714) <0.001 0.562 (0.386-0.818) 0.003
GENDER 503
Male 235 Reference
female sex 268 0.910 (0.647-1.281) 0.590
AJCC staging 503
Phase I 280 Reference
Phase II 118 2.217 (1.453-3.381) <0.001 1.187 (0.582-2.418) 0.637
Phase III 79 3.008 (1.912-4.732) <0.001 1.673 (0.573-4.884) 0.347
Stage IV 26 3.771 (2.044-6.956) <0.001 8.033 (0.618-104.471) 0.111
M 503
M0 336 Reference
M1 25 2.250 (1.229-4.118) 0.009 0.260 (0.021-3.284) 0.298
MX 142 0.929 (0.617-1.400) 0.725 1.075 (0.702-1.645) 0.741
N 503
N3 14 Reference
N0 330 0.869 (0.273-2.767) 0.812 1.519 (0.357-6.472) 0.572
N1 90 1.939 (0.597-6.301) 0.271 2.750 (0.609-12.417) 0.188
N2 69 2.389 (0.724-7.880) 0.153 2.358 (0.484-11.481) 0.288
T 503
T1 170 Reference
T2 266 1.585 (1.044-2.408) 0.031 1.197 (0.773-1.853) 0.420
T3 18 3.108 (1.426-6.771) 0.004 1.359 (0.549-3.367) 0.507
T4 49 2.765 (1.521-5.026) <0.001 1.997 (0.956-4.170) 0.066
Smoking 503
yes 421 Reference
no 82 0.922 (0.583-1.458) 0.728
Age 503
>65 256 Reference
≤65 247 0.817 (0.580-1.151) 0.248